Menu utilisateur

Accès à distance ? S'identifier sur le proxy UCLouvain | Saint-Louis

Rechercher

Affichage: 1 - 25 sur 27 résultats.

Pages

    • Article de périodique
    ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥4 baseline): Final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial
    Mounier, N. Brice, P. Bologna, S. Briere, J. Gaillard, I. Heczko, M. Gabarre, J. Casasnovas, O. Jaubert, J. Colin, P. Delmer, A. Devidas, A. Bachy, E. Nicolas-Virelizier, E. Aoudjhane, A. Humbrecht, C. André, M.[UCL] Carde, P. Divine, M. Fenaux, P. Coiffier, B. Reman, O. Aoudjhane, M. Blaise, A.M. Bordessoule, D. Bosly, André[UCL] Morschhauser, F. Caillot, D. Gonzalez, H. Lederlin, P. Bouabdallah, R. van Hoof, A. Boulat, O. Bauduer, F. Tournilhac, O. Decaudin, D. Sebban, C. Janvier, M. Kentos, A. Voillat, L. Fabbro, M. Eisenmann, J.C. Martin, C. Christian, B. Ferrant, Augustin[UCL] Salanoubat, C. Varet, B. Bouabdallah, K. de Prijck, B. Levaltier, X. Castaigne, S. Audhuy, B. Frenkiel, N. Rose, C. Fitoussi, O. Orfeuvre, H. Pignon, J.M. (2014) Annals of Oncology — Vol. 25, no.8, p. 1622-1628 (2014)
    • Article de périodique
    Rituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II lymphoma study Association trial
    Mounier, N. El Gnaoui, T. Tilly, H. Canioni, D. Sebban, C. Casasnovas, R.-O. Delarue, R. Sonet, Anne[UCL] Beaussart, P. Petrella, T. Castaigne, S. Bologna, S. Salles, G. Rahmouni, A. Gaulard, P. Haioun, C. (2013) Haematologica : journal of hematology — Vol. 98, no.11, p. 1726-1731 (2013)
    • Article de périodique
    Risk-adapted salvage treatment with single or tandem autologous stem-cell transplantation for first relapse/refractory Hodgkin's lymphoma: Results of the prospective multicenter H96 trial by the GELA/SFGM study group
    Morschhauser, F. Brice, P. Fermé, C. Diviné, M. Salles, G. Bouabdallah, R. Sebban, C. Voillat, L. Casasnovas, O. Stamatoullas, A. Bouabdallah, K. André, Marc Jais, J.-P. Cazals-Hatem, D. Gisselbrecht, C. (2008) Journal of Clinical Oncology — Vol. 26, no.36, p. 5980-5987 (2008)
    • Article de périodique
    Prognostic-significance of Received Relative Dose Intensity in Non-hodgkins-lymphoma Patients - Application To Lnh-87 Protocol
    Lepage, E. Gisselbrecht, C. Haioun, C. Sebban, C. Tilly, H. Bosly, André[UCL] Morel, Priscilla[UCL] Herbrecht, R. Reyes, F. Coiffier, B. (1993) Annals of Oncology — Vol. 4, no. 8, p. 651-656 (1993)
    • Communication
    Bone-marrow Transplantation Prolongs Survival After Relapse in Lymphoma Patients - Long-term Follow-up
    Bosly, André[UCL] Coiffier, B. Tilly, H. Herbrecht, R. Legros, M. Sebban, C. Simon, M. Salles, G. Martiat, P. Jaubert, J. Gisselbrecht, C. (1993) —
    • Communication
    Rituximab plus CHOP (R-CHOP) in the treatment of elderly patients with diffuse large B-cell lymphoma. An update of the GELA study.
    Coiffier, B. Ferme, C Hermine, O. Haioun, C. Baumelou, E Solal-Celigny, P. Delmer, A. Sebban, C. Mounier, N. Tertian, G Van Hoof, A. Bosly, André[UCL] (2001) —
    • Communication
    Long-term follow-up of the C5R protocol of high-dose chemotherapy and radiotherapy in 100 newly diagnosed primary CNS lymphomas: A prospective multicentric phase II study of the gela
    Ghesquieres, H. Ferlay, C. Sebban, C. Casasnovas, O. Reman, O. Bosly, André[UCL] Coiffier, B. Biron, P. Blay, J. (2008) 10th International Conference on Malignant Lymphoma — Lugano(Switzerland)
    • Communication
    Superiority of late over early intensification in relapsing/refractory aggressive non-Hodgkin's lymphoma: A randomized study from the GELA: LNH RP 93
    Bosly, André[UCL] Ferrant, Augustin[UCL] Sonet, Anne Salles, G. Brice, P. Haioun, C. Kerneis, Y Tilly, H. Lederlin, P. Plantier, I Sebban, C. Gisselbrecht, C. Coiffier, B. (1998) —
    • Article de périodique
    Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: A study by the groupe d'Etude des lymphomes de l'adulte
    Feugier, P Van Hoof, A. Sebban, C. Solal-Celigny, P. Bouabdallah, R. Ferme, C Christian, B. Lepage, E. Tilly, H. Morschhauser, F. Gaulard, P. Salles, G. Bosly, André[UCL] Gisselbrecht, C. Reyes, F. Coiffier, B. (2005) Journal of Clinical Oncology — Vol. 23, no. 18, p. 4117-4126 (2005)
    • Article de périodique
    Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective multicentric phase II study of the Groupe d'Etude des Lymphomes de l'Adulte (GELA)
    Ghesquieres, H. Van Den Neste, Eric[UCL] Ferlay, C. Sebban, C. Perol, D. Bosly, André[UCL] Casasnovas, O. Reman, O. Coiffier, B. Tilly, H. Morel, Priscilla[UCL] Colin, P. Haioun, C. Biron, P. Blay, J. -Y. (2010) Annals of Oncology — Vol. 21, no. 4, p. 842-50 (2010)
    • Article de périodique
    Parenthood in survivors of Hodgkin lymphoma: An EORTC-GELA general population case-control study
    Van Der Kaaij, M.A.E. Heutte, N. Meijnders, P. Abeilard-Lemoisson, E. Spina, M. Moser, L.C. Allgeier, A. Meulemans, B. Dubois, B. Simons, A.H.M. Lugtenburg, P.J. Aleman, B.M.P. Noordijk, E.M. Fermé, C. Thomas, J. Stamatoullas, A. Fruchart, C. Brice, P. Gaillard, I. Doorduijn, J.K. Sebban, C. Smit, W.G.J.M. Bologna, S. Roesink, J.M. Ong, F. André, Marc[UCL] Raemaekers, J.M.M. Henry-Amar, M. Kluin-Nelemans, H.C. (2012) Journal of Clinical Oncology — Vol. 30, no.31, p. 3854-3863 (2012)
    • Article de périodique
    Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma
    Bachy, E. Houot, R. Morschhauser, F. Sonet, Anne[UCL] Brice, P. Belhadj, K. Cartron, G. Audhuy, B. Fermé, C. Feugier, P. Sebban, C. Delwail, V. Maisonneuve, H. Le Gouill, S. Lefort, S. Brousse, N. Foussard, C. Salles, G. (2013) Haematologica : journal of hematology — Vol. 98, no.7, p. 1107-1114 (2013)
    • Article de périodique
    Cryopreservation, semen use and the likelihood of fatherhood in male Hodgkin lymphoma survivors: An EORTC-GELA lymphoma group cohort study
    Van Der Kaaij, M.A.E. Van Echten-Arends, J. Heutte, N. Meijnders, P. Abeilard-Lemoisson, E. Spina, M. Moser, E.C. Allgeier, A. Meulemans, B. Lugtenburg, P.J. Aleman, B.M.P. Noordijk, E.M. Fermé, C. Thomas, J. Stamatoullas, A. Fruchart, C. Eghbali, H. Brice, P. Smit, W.G.J.M. Sebban, C. Doorduijn, J.K. Roesink, J.M. Gaillard, I. Coiffier, B. Lybeert, M.L.M. Casasnovas, O. André, Marc[UCL] Raemaekers, J.M.M. Henry-Amar, M. Kluin-Nelemans, J.C. (2014) Human Reproduction — Vol. 29, no.3, p. 525-533 (2014)
    • Article de périodique
    Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: Final analysis of the prospective LNH87-2 protocol - A Groupe d'Etude des Lymphomes de l'Adulte Study
    Haioun, C. Lepage, E. Gisselbrecht, C. Salles, G. Coiffier, B. Brice, P. Bosly, André[UCL] Morel, Priscilla[UCL] Nouvel, C. Tilly, H. Lederlin, P. Sebban, C. Briere, J Gaulard, P. Reyes, F. (2000) Journal of Clinical Oncology — Vol. 18, no. 16, p. 3025-3030 (2000)
    • Article de périodique
    Treatment of acute lymphoblastic leukemia in the elderly: An evaluation of interferon alpha given as a single agent after complete remission
    Delannoy, A. Cazin, B. Thomas, X. Bouabdallah, R. Boiron, J.M. Huguet, F. Straetmans, N.[UCL] Zérazhi, H. Vernant, J.P. Dombret, H. Bilhou-Nabera, C. Charrin, C. Boucheix, C. Sebban, C. Lhéritier, V. Fière, D. (2002) Leukemia and Lymphoma — Vol. 43, no. 1, p. 75-81 (2002)
    • Article de périodique
    Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after six cycles of chemotherapy for patients with advanced Hodgkin's disease: results of the Groupe d'etudes des Lymphomes de l'Adulte H89 trial
    Ferme, C Ferrant, Augustin[UCL] Sebban, C. Hennequin, C Divine, M. Lederlin, P. Gabarre, J Caillot, D. Bordessoule, D. Brice, P. Moullet, I Berger, F. Lepage, E. (2000) Blood — Vol. 95, no. 7, p. 2246-2252 (2000)
    • Communication
    Late intensification is superior to early intensification in relapsing/refractory aggressive non-Hodgkin's lymphoma. A randomized study from the GELA: LNH RP93.
    Bosly, André[UCL] Sonet, Anne Salles, G. Brice, P. Haioun, C. Kerneis, Y Tilly, H. Lederlin, P. Plantier, I Sebban, C. Coiffier, B. (1997) —
    • Article de périodique
    Randomized comparison of ACVBP and m-BACOD in the treatment of patients with low-risk aggressive lymphoma: The LNH87-1 study
    Tilly, H. Mounier, N. Lederlin, P. Briere, J Dupriez, B. Sebban, C. Bosly, André[UCL] Biron, P. Nouvel, C. Herbrecht, R. Bordessoule, D. Coiffier, B. (2000) Journal of Clinical Oncology — Vol. 18, no. 6, p. 1309-1315 (2000)
    • Communication
    Superiority of late over early intensification in relapsing/refractory aggressive non-Hodgkin's lymphoma: A randomized study from the GELA: LNH RP 93.
    Bosly, André[UCL] Ferrant, Augustin[UCL] Sonet, Anne Salles, G. Brice, P. Haioun, C. Kerneis, Y Tilly, H. Lederlin, P. Plantier, I Sebban, C. Gisselbrecht, C. Coiffier, B. (1998) —
    • Communication
    Superiority of late over early intensification in relapsing/refractory aggressive non-Hodgkin's lymphoma: A randomized study from the GELA: LNH RP 93.
    Bosly, André[UCL] Sonet, Anne Salles, G. Brice, P. Haioun, C. Kerneis, Y Tilly, H. Lederlin, P. Plantier, I Sebban, C. Gisselbrecht, C. Coiffier, B. (1997) —
    • Communication
    90yttrium Ibritumomab Tiuxetan (zevalin) Combined With Beam (z-beam) Conditioning Regimen Plus Autologous Stem Cell Transplantation in Relapsed Or Refractory Follicular Lymphoma. a Gela Phase Ii Prospective Study
    Gisselbrecht, C. Decaudin, D. Mounier, N. Tilly, H. Ribrag, V. Sebban, C. Milpied, N. Morschhauser, F. Coiffier, B. Le Gouill, S. Lederlin, P. Delarue, R. Laurent, Gabrielle[UCL] Bosly, André[UCL] (2009) 14th Annual Meeting of the European-Hematology-Association — Berlin(Germany)
    • Communication
    Ancestim (stem cell factor, SCF) in combination with filgrastim can mobilize sufficient peripheral blood progenitor cells (PBPC) to support high-dose salvage chemotherapy and late intensification in relapsing and refractory aggressive non-Hodgkin's lymphoma. A GELA study.
    Haioun, C. Ferrant, Augustin[UCL] Van Hoof, A. Thieblemont, C Hulin, C. Mounier, N. Tilly, H. Sebban, C. Allain, A Lepage, E. Osselaer, Jean-Claude[UCL] Beaujean, F Vannerom, H Cailliot, C Bosly, André[UCL] (2003) 45th Annual Meeting of the American-Society-of-Hematology — SAN DIEGO (California)
    • Communication
    A prospective multicentric phase II study of the C5R regimen in patients with primary cerebral lymphoma: Analysis on 70 patients.
    Blay, J. -Y. Perol, D. Sebban, C. Bosly, André[UCL] Casasnovas, O. Reman, O. Coiffier, B. Morel, Priscilla[UCL] (2001) —
    • Article de périodique
    Rituximab plus CHOP (R-CHOP) overcomes bcl-2-associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)
    Mounier, N. Briere, J Gisselbrecht, C. Emile, JF Lederlin, P. Sebban, C. Berger, F. Bosly, André[UCL] Morel, Priscilla[UCL] Tilly, H. Bouabdallah, R. Reyes, F. Gaulard, P. Coiffier, B. (2003) Blood — Vol. 101, no. 11, p. 4279-4284 (2003)
    • Article de périodique
    Sequential Induction Chemotherapy With Vincristine, Daunorubicin, Cyclophosphamide, and Prednisone in Adult Acute Lymphoblastic-leukemia
    Thomas, X. Danaila, C. Bach, QK. Dufour, Philippe[UCL] Christian, B. Corront, B. Bosly, André[UCL] Bastion, Y. Gratecos, N. Leblay, R. Sebban, C. Archimbaud, E. Fiere, D. (1995) Annals of Hematology — Vol. 70, no. 2, p. 65-69 (1995)

Pages